Literature DB >> 19765488

Hypertension in the elderly.

Maria Czarina Acelajado1, Suzanne Oparil.   

Abstract

Hypertension is an important risk factor for cardiovascular morbidity and mortality, particularly in the elderly. Blood pressure elevation in the elderly is due to structural and functional changes that occur with aging. Treatment of hypertension reduces the risk of stroke, heart failure, myocardial infarction, all-cause mortality, cognitive impairment, and dementia in elderly patients with hypertension. A healthy lifestyle helps hypertension management, with benefits extending beyond lowering of blood pressure. Several classes of antihypertensive drugs are effective in preventing cardiovascular events. Treatment decisions should be guided by the presence of compelling indications such as diabetes or heart failure and by the tolerability of individual drugs or drug combinations in individual patients. The concomitant intake of certain medications that counter the effects of antihypertensive drugs and the frequent occurrence of orthostatic hypotension complicate treatment in older patients and drive down blood pressure control rates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765488     DOI: 10.1016/j.cger.2009.06.001

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  15 in total

Review 1.  Public health options for improving cardiovascular health among older Americans.

Authors:  Kurt J Greenlund; Nora L Keenan; Paula F Clayton; Dilip K Pandey; Yuling Hong
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

Review 2.  Sex differences in mechanisms of arterial stiffness.

Authors:  Jennifer J DuPont; Rachel M Kenney; Ayan R Patel; Iris Z Jaffe
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

3.  Whole rat DNA array survey for candidate genes related to hypertension in kidneys from three spontaneously hypertensive rat substrains at two stages of age and with hypotensive induction caused by hydralazine hydrochloride.

Authors:  Kosho Kinoshita; Mohammad Said Ashenagar; Masaki Tabuchi; Hideaki Higashino
Journal:  Exp Ther Med       Date:  2011-01-14       Impact factor: 2.447

4.  Arrhythmogenic Remodeling in Murine Models of Deoxycorticosterone Acetate-Salt-Induced and 5/6-Subtotal Nephrectomy-Salt-Induced Cardiorenal Disease.

Authors:  Magda S C Fontes; Diana A Papazova; Arianne van Koppen; Sanne de Jong; Sanne M Korte; Lennart G Bongartz; Tri Q Nguyen; Marti F A Bierhuizen; Teun P de Boer; Toon A B van Veen; Marianne C Verhaar; Jaap A Joles; Harold V M van Rijen
Journal:  Cardiorenal Med       Date:  2015-06-05       Impact factor: 2.041

Review 5.  Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.

Authors:  Stefano Omboni; Ettore Malacco; Jean-Michel Mallion; Paolo Fabrizzi; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-17

6.  Optimal management of hypertension in elderly patients.

Authors:  Maria Czarina Acelajado
Journal:  Integr Blood Press Control       Date:  2010-11-11

Review 7.  Essential hypertension: an approach to its etiology and neurogenic pathophysiology.

Authors:  Juan J Bolívar
Journal:  Int J Hypertens       Date:  2013-12-09       Impact factor: 2.420

8.  Sex differences in the time course and mechanisms of vascular and cardiac aging in mice: role of the smooth muscle cell mineralocorticoid receptor.

Authors:  Jennifer J DuPont; Seung Kyum Kim; Rachel M Kenney; Iris Z Jaffe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-23       Impact factor: 4.733

9.  Effect of long-term resistance exercise on body composition, blood lipid factors, and vascular compliance in the hypertensive elderly men.

Authors:  Hyun-Sub Kim; Dae-Geun Kim
Journal:  J Exerc Rehabil       Date:  2013-04-25

10.  Chapter 2: Lifestyle and pharmacological treatments for lowering blood pressure in CKD ND patients.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.